What do we know about the inflammasome in humans?

Area of Science:

• Immunology
• Cell Biology
• Molecular Medicine

Background:

• The inflammasome is a critical component of the innate immune system, involved in host defense against pathogens and cellular damage.
• While extensively studied in animal models, understanding inflammasome function in human physiology and disease remains limited.
• The inflammasome pathway culminates in caspase activation, interleukin-1β release, and pyroptosis (inflammatory cell death).

Purpose of the Study:

• To review the molecular structure and activation mechanisms of inflammasomes, with a specific focus on human expression.
• To consolidate current knowledge on inflammasome involvement in human health and disease.
• To emphasize the need for increased research on human inflammasome complexes.

Main Methods:

• Literature review of original research articles and reviews on inflammasome biology.
• Analysis of studies investigating inflammasome components in human tissues (in vivo and ex vivo).
• Examination of evidence linking inflammasomes to human inflammatory, neoplastic, and neurodegenerative disorders.

Main Results:

• Inflammasome components have been identified in various human tissues, including peripheral and brain tissues.
• The inflammasome complex is implicated in the pathogenesis of several human genetic and acquired inflammatory and neoplastic diseases.
• Despite existing data, significant gaps remain in understanding human inflammasome function and its disease associations.

Conclusions:

• Further research prioritizing human tissues is crucial for a comprehensive understanding of inflammasome roles in disease.
• Modulating inflammasome activity presents a promising therapeutic strategy for inflammatory and neurodegenerative diseases.
• Ongoing clinical trials are investigating the therapeutic potential of targeting the inflammasome pathway.